Roxanne Pero
Dallas, TXNPI 1508069790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 35.2% of the total. Reporting peaked in 2021 at $429 and has fallen 96.7% since, to $14 in 2025.
Across 74 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$394
- Avanos Medical$92
- Therapeuticsmd, Inc.$69
- Smith+Nephew$68
- Pfizer$55
- Vertical Pharmaceuticals, LLC$51
- plus $392 from 17 others
Across 137 payments — averaging $9671.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$840K
- GSK$485K
What the payments were for
- Food & beverage$1,09498%
- Education$262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $394 |
| Avanos Medical | 4 | $92 |
| Therapeuticsmd, Inc. | 5 | $69 |
| Smith+Nephew | 3 | $68 |
| Pfizer | 4 | $55 |
| Vertical Pharmaceuticals, LLC | 3 | $51 |
| Exeltis, USA Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Merck | 3 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| AMAG Pharmaceuticals, Inc. | 2 | $26 |
| Biom'up France SAS | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
| Coopersurgical, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Kedrion Biopharma Inc. | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $14 |
| Organon | 1 | $14 |
| Pylant Medical | 1 | $14 |
| Lupin Inc. | 1 | $13 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.